Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndrome
Public ClinicalTrials.gov record NCT07450664. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Observational Study of VYKAT™ XR (Diazoxide Choline Extended-Release Tablets) in Patients With Prader-Willi Syndrome (PWS)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Prospective observational study developed to generate more evidence of the safety profile, clinical characteristics and outcomes of patients with PWS treated with VYKAT XR.
Study identification
- NCT ID
- NCT07450664
- Recruitment status
- Enrolling by invitation
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 4 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 25, 2025
- Primary completion
- Feb 29, 2028
- Completion
- Mar 1, 2028
- Last update posted
- Aug 20, 2026
2025 – 2028
United States locations
- U.S. sites
- 24
- U.S. states
- 18
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Neurocrine Clinical Site | Phoenix | Arizona | 85016 | — |
| Neurocrine Clinical Site | Los Angeles | California | 90027 | — |
| Neurocrine Clinical Site | Sacramento | California | 95821 | — |
| Neurocrine Clinical Site | Aurora | Colorado | 80045 | — |
| Neurocrine Clinical Site | Atlanta | Georgia | 30322 | — |
| Neurocrine Clinical Site | Chicago | Illinois | 60611 | — |
| Neurocrine Clinical Site | Indianapolis | Indiana | 46202 | — |
| Neurocrine Clinical Site | Boston | Massachusetts | 02115 | — |
| Neurocrine Clinical Site | Ann Arbor | Michigan | 48109 | — |
| Neurocrine Clinical Site | Lansing | Michigan | 48912 | — |
| Neurocrine Clinical Site | Minneapolis | Minnesota | 55454 | — |
| Neurocrine Clinical Site | Rochester | Minnesota | 55905 | — |
| Neurocrine Clinical Site | Saint Paul | Minnesota | 55102 | — |
| Neurocrine Clinical Site | Kansas City | Missouri | 64111 | — |
| Neurocrine Clinical Site | Paterson | New Jersey | 07503 | — |
| Neurocrine Clinical Site | Valley Stream | New York | 11580 | — |
| Neurocrine Clinical Site | Chapel Hill | North Carolina | 27514 | — |
| Neurocrine Clinical Site | Durham | North Carolina | 27710 | — |
| Neurocrine Clinical Site | Portland | Oregon | 97227 | — |
| Neurocrine Clinical Site | Nashville | Tennessee | 37232 | — |
| Neurocrine Clinical Site | Dallas | Texas | 75231 | — |
| Neurocrine Clinical Site | Houston | Texas | 77030 | — |
| Neurocrine Clinical Site | Salt Lake City | Utah | 84108 | — |
| Neurocrine Clinical Site | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07450664, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 20, 2026 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07450664 live on ClinicalTrials.gov.